Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease IJ Martins, E Hone, JK Foster, SI Sünram-Lea, A Gnjec, SJ Fuller, D Nolan, ... Molecular psychiatry 11 (8), 721-736, 2006 | 503 | 2006 |
Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription SM Laws, E Hone, S Gandy, RN Martins Journal of neurochemistry 84 (6), 1215-1236, 2003 | 317 | 2003 |
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease P Chatterjee, S Pedrini, NJ Ashton, M Tegg, K Goozee, AK Singh, ... Alzheimer's & Dementia 18 (6), 1141-1154, 2022 | 139 | 2022 |
Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes M Mirzaei, VB Gupta, JM Chick, TM Greco, Y Wu, N Chitranshi, RV Wall, ... Scientific reports 7 (1), 12685, 2017 | 136 | 2017 |
Alzheimer’s disease: a journey from amyloid peptides and oxidative stress, to biomarker technologies and disease prevention strategies—gains from AIBL and DIAN cohort studies RN Martins, V Villemagne, HR Sohrabi, P Chatterjee, TM Shah, G Verdile, ... Journal of Alzheimer's Disease 62 (3), 965-992, 2018 | 130 | 2018 |
Apolipoprotein E influences amyloid-beta clearance from the murine periphery E Hone, IJ Martins, J Fonte, RN Martins Journal of Alzheimer's Disease 5 (1), 1-8, 2003 | 97 | 2003 |
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease K Dhiman, VB Gupta, VL Villemagne, D Eratne, PL Graham, C Fowler, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 12 (1 …, 2020 | 92 | 2020 |
Gonadotropins and cognition in older women MA Rodrigues, G Verdile, JK Foster, E Hogervorst, K Joesbury, ... Journal of Alzheimer's Disease 13 (3), 267-274, 2008 | 77 | 2008 |
Reduction of inclusion body pathology in ApoE-deficient mice fed a combination of antioxidants G Veurink, DAN Liu, K Taddei, G Perry, MA Smith, TA Robertson, E Hone, ... Free Radical Biology and Medicine 34 (8), 1070-1077, 2003 | 75 | 2003 |
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease NJ Ashton, AJ Nevado-Holgado, IS Barber, S Lynham, V Gupta, ... Science advances 5 (2), eaau7220, 2019 | 74 | 2019 |
Variation at the APOE− 491 promoter locus is associated with altered brain levels of apolipoprotein E SM Laws, E Hone, K Taddei, C Harper, B Dean, C McClean, C Masters, ... Molecular psychiatry 7 (8), 886-890, 2002 | 71 | 2002 |
APOE genotype results in differential effects on the peripheral clearance of amyloid-β 42 in APOE knock-in and knock-out mice MJ Sharman, M Morici, E Hone, T Berger, K Taddei, IJ Martins, WLF Lim, ... Journal of Alzheimer's Disease 21 (2), 403-409, 2010 | 67 | 2010 |
Relative roles of LDLr and LRP in the metabolism of chylomicron remnants in genetically manipulated mice IJ Martins, E Hone, C Chi, U Seydel, RN Martins, TG Redgrave Journal of lipid research 41 (2), 205-213, 2000 | 64 | 2000 |
Autophagy modulation as a treatment of amyloid diseases Z Mputhia, E Hone, T Tripathi, T Sargeant, R Martins, P Bharadwaj Molecules 24 (18), 3372, 2019 | 61 | 2019 |
Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia B Dean, SM Laws, E Hone, K Taddei, E Scarr, EA Thomas, C Harper, ... Biological psychiatry 54 (6), 616-622, 2003 | 56 | 2003 |
Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging VB Gupta, JD Doecke, E Hone, S Pedrini, SM Laws, M Thambisetty, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 3 (1), 18-26, 2016 | 54 | 2016 |
Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes CB Pocernich, R Sultana, E Hone, J Turchan, RN Martins, V Calabrese, ... Journal of neuroscience research 77 (4), 532-539, 2004 | 50 | 2004 |
Profiling brain and plasma lipids in human apoe ε2, ε3, and ε4 knock-in mice using electrospray ionization mass spectrometry MJ Sharman, G Shui, AZ Fernandis, WLF Lim, T Berger, E Hone, K Taddei, ... Journal of Alzheimer's Disease 20 (1), 105-111, 2010 | 42 | 2010 |
Alzheimer's disease amyloid-beta peptide modulates apolipoprotein E isoform specific receptor binding E Hone, IJ Martins, M Jeoung, TH Ji, SE Gandy, RN Martins Journal of Alzheimer's disease 7 (4), 303-314, 2005 | 42 | 2005 |
Altered levels of blood proteins in Alzheimer's disease longitudinal study: Results from Australian Imaging Biomarkers Lifestyle Study of Ageing cohort VB Gupta, E Hone, S Pedrini, J Doecke, S O'Bryant, I James, AI Bush, ... Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 8, 60-72, 2017 | 36 | 2017 |